English

CABALETTA BIO, INC.

EDGAR

CABA Quarterly report (10-Q) · filed 2026-08-13

44 filing records in this dataset, filed from 2018-12-10 to 2026-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 225 million USD 2026-06-30 Source
Exact value

225101000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 100 million shares 2025-12-31 Source
Exact value

100479323 shares

Reported share-count change

98.02% · 49.7 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

50743101 shares · 2024-12-31· Source
100479323 shares · 2025-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-181 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -44866000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -167856000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -125937000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -43515000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -51018000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-154 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -95737000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -61228000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -131080000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -95737000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -42561000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -84075000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -42561000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

283 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 1024000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 946000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 1229000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 1024000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 0 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-154 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -95737000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -61228000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -131080000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -95737000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -42561000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -84075000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -42561000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 1024000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 946000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 1229000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 1024000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 0 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 5 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 51.99 million

Prior period

−USD 115.86 million

2024-01-01 – 2024-12-31
Current period

−USD 167.86 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-167856000 − -115864000 = -51992000 USD

-115864000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-167856000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CABALETTA BIO, INC. · 2025-12-31 CABALETTA BIO, INC. (edgar:1759138) Year-over-year change in Net income: -51992000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -167856000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2644441 Filing: 000175913826000011 Input fundies:NetIncome: -115864000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2646196 Filing: 000175913826000011
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 42.86 million

Prior period

−USD 88.22 million

2024-01-01 – 2024-12-31
Current period

−USD 131.08 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-131080000 − -88222000 = -42858000 USD

-88222000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-131080000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CABALETTA BIO, INC. · 2025-12-31 CABALETTA BIO, INC. (edgar:1759138) Year-over-year change in Operating cash flow: -42858000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -131080000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2197147 Filing: 000175913826000011 Input fundies:OperatingCashFlow: -88222000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2199007 Filing: 000175913826000011
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-44.4%

Prior period

USD 2.21 million

2024-01-01 – 2024-12-31
Current period

USD 1.23 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1229000 − 2211000 = -982000 USD

2211000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1229000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CABALETTA BIO, INC. · 2025-12-31 CABALETTA BIO, INC. (edgar:1759138) Year-over-year change in Capital expenditure: -982000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1229000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2203857 Filing: 000175913826000011 Input fundies:CapitalExpenditure: 2211000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2205602 Filing: 000175913826000011
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 12.2 million Exact value Exact value: -12202000 USD 2018-01-01 – 2018-12-31: -12202000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2018-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -12202000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12202000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459020013929/caba-20191231.xml#106733 Filing: 000156459020013929 The citation records this snapshot. The page link may show a newer release later.	−USD 4.66 million Exact value Exact value: -4661000 USD 2018-01-01 – 2018-12-31: -4661000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2018-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -4661000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4661000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459020013929/caba-20191231.xml#123596 Filing: 000156459020013929 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 16.94 million Exact value Exact value: -16943000 USD 2019-01-01 – 2019-12-31: -16943000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2019-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -16943000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16943000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459021013329/caba-20201231.xml#110440 Filing: 000156459021013329 The citation records this snapshot. The page link may show a newer release later.	−USD 16.05 million Exact value Exact value: -16045000 USD 2019-01-01 – 2019-12-31: -16045000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2019-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -16045000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16045000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459021013329/caba-20201231.xml#127872 Filing: 000156459021013329 The citation records this snapshot. The page link may show a newer release later.	USD 693,000 Exact value Exact value: 693000 USD 2019-01-01 – 2019-12-31: 693000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CABALETTA BIO, INC. · 2019-12-31 CABALETTA BIO, INC. (edgar:1759138) Capital Expenditure: 693000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 693000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459021013329/caba-20201231.xml#128293 Filing: 000156459021013329 The citation records this snapshot. The page link may show a newer release later.	−USD 16.74 million Calculation and evidence -16045000 − 693000 USD Exact free cash flow: -16738000 USD 2019-01-01 – 2019-12-31: -16045000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 693000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CABALETTA BIO, INC. · 2019-12-31 CABALETTA BIO, INC. (edgar:1759138) Free cash flow: -16738000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16045000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459021013329/caba-20201231.xml#127872 Filing: 000156459021013329 Input fundies:CapitalExpenditure: 693000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459021013329/caba-20201231.xml#128293 Filing: 000156459021013329 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 33.34 million Exact value Exact value: -33339000 USD 2020-01-01 – 2020-12-31: -33339000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2020-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -33339000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33339000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459022010726/caba-10k_20211231.htm#1980356 Filing: 000156459022010726 The citation records this snapshot. The page link may show a newer release later.	−USD 26.77 million Exact value Exact value: -26770000 USD 2020-01-01 – 2020-12-31: -26770000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2020-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -26770000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26770000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459022010726/caba-10k_20211231.htm#2122428 Filing: 000156459022010726 The citation records this snapshot. The page link may show a newer release later.	USD 635,000 Exact value Exact value: 635000 USD 2020-01-01 – 2020-12-31: 635000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CABALETTA BIO, INC. · 2020-12-31 CABALETTA BIO, INC. (edgar:1759138) Capital Expenditure: 635000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 635000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459022010726/caba-10k_20211231.htm#2130093 Filing: 000156459022010726 The citation records this snapshot. The page link may show a newer release later.	−USD 27.41 million Calculation and evidence -26770000 − 635000 USD Exact free cash flow: -27405000 USD 2020-01-01 – 2020-12-31: -26770000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 635000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CABALETTA BIO, INC. · 2020-12-31 CABALETTA BIO, INC. (edgar:1759138) Free cash flow: -27405000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26770000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459022010726/caba-10k_20211231.htm#2122428 Filing: 000156459022010726 Input fundies:CapitalExpenditure: 635000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000156459022010726/caba-10k_20211231.htm#2130093 Filing: 000156459022010726 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 46.29 million Exact value Exact value: -46289000 USD 2021-01-01 – 2021-12-31: -46289000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2021-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -46289000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46289000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017023008298/caba-20221231.htm#2075405 Filing: 000095017023008298 The citation records this snapshot. The page link may show a newer release later.	−USD 34.11 million Exact value Exact value: -34109000 USD 2021-01-01 – 2021-12-31: -34109000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2021-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -34109000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34109000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017023008298/caba-20221231.htm#2259682 Filing: 000095017023008298 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1166000 USD 2021-01-01 – 2021-12-31: 1166000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CABALETTA BIO, INC. · 2021-12-31 CABALETTA BIO, INC. (edgar:1759138) Capital Expenditure: 1166000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1166000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017023008298/caba-20221231.htm#2267635 Filing: 000095017023008298 The citation records this snapshot. The page link may show a newer release later.	−USD 35.28 million Calculation and evidence -34109000 − 1166000 USD Exact free cash flow: -35275000 USD 2021-01-01 – 2021-12-31: -34109000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1166000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CABALETTA BIO, INC. · 2021-12-31 CABALETTA BIO, INC. (edgar:1759138) Free cash flow: -35275000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34109000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017023008298/caba-20221231.htm#2259682 Filing: 000095017023008298 Input fundies:CapitalExpenditure: 1166000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017023008298/caba-20221231.htm#2267635 Filing: 000095017023008298 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 52.98 million Exact value Exact value: -52975000 USD 2022-01-01 – 2022-12-31: -52975000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2022-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -52975000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52975000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017024034422/caba-20231231.htm#1746076 Filing: 000095017024034422 The citation records this snapshot. The page link may show a newer release later.	−USD 46.38 million Exact value Exact value: -46380000 USD 2022-01-01 – 2022-12-31: -46380000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2022-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -46380000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46380000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017024034422/caba-20231231.htm#1858580 Filing: 000095017024034422 The citation records this snapshot. The page link may show a newer release later.	USD 2.45 million Exact value Exact value: 2453000 USD 2022-01-01 – 2022-12-31: 2453000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CABALETTA BIO, INC. · 2022-12-31 CABALETTA BIO, INC. (edgar:1759138) Capital Expenditure: 2453000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2453000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017024034422/caba-20231231.htm#1863433 Filing: 000095017024034422 The citation records this snapshot. The page link may show a newer release later.	−USD 48.83 million Calculation and evidence -46380000 − 2453000 USD Exact free cash flow: -48833000 USD 2022-01-01 – 2022-12-31: -46380000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 2453000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CABALETTA BIO, INC. · 2022-12-31 CABALETTA BIO, INC. (edgar:1759138) Free cash flow: -48833000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46380000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017024034422/caba-20231231.htm#1858580 Filing: 000095017024034422 Input fundies:CapitalExpenditure: 2453000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017024034422/caba-20231231.htm#1863433 Filing: 000095017024034422 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 67.68 million Exact value Exact value: -67675000 USD 2023-01-01 – 2023-12-31: -67675000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2023-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -67675000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -67675000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017025047201/caba-20241231.htm#3010423 Filing: 000095017025047201 The citation records this snapshot. The page link may show a newer release later.	−USD 53.55 million Exact value Exact value: -53549000 USD 2023-01-01 – 2023-12-31: -53549000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2023-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -53549000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53549000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017025047201/caba-20241231.htm#2558562 Filing: 000095017025047201 The citation records this snapshot. The page link may show a newer release later.	USD 687,000 Exact value Exact value: 687000 USD 2023-01-01 – 2023-12-31: 687000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CABALETTA BIO, INC. · 2023-12-31 CABALETTA BIO, INC. (edgar:1759138) Capital Expenditure: 687000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 687000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017025047201/caba-20241231.htm#2564705 Filing: 000095017025047201 The citation records this snapshot. The page link may show a newer release later.	−USD 54.24 million Calculation and evidence -53549000 − 687000 USD Exact free cash flow: -54236000 USD 2023-01-01 – 2023-12-31: -53549000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 687000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CABALETTA BIO, INC. · 2023-12-31 CABALETTA BIO, INC. (edgar:1759138) Free cash flow: -54236000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -53549000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017025047201/caba-20241231.htm#2558562 Filing: 000095017025047201 Input fundies:CapitalExpenditure: 687000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000095017025047201/caba-20241231.htm#2564705 Filing: 000095017025047201 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 115.86 million Exact value Exact value: -115864000 USD 2024-01-01 – 2024-12-31: -115864000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2024-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -115864000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -115864000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2646196 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.	−USD 88.22 million Exact value Exact value: -88222000 USD 2024-01-01 – 2024-12-31: -88222000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2024-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -88222000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -88222000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2199007 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.	USD 2.21 million Exact value Exact value: 2211000 USD 2024-01-01 – 2024-12-31: 2211000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CABALETTA BIO, INC. · 2024-12-31 CABALETTA BIO, INC. (edgar:1759138) Capital Expenditure: 2211000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2211000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2205602 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.	−USD 90.43 million Calculation and evidence -88222000 − 2211000 USD Exact free cash flow: -90433000 USD 2024-01-01 – 2024-12-31: -88222000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 2211000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CABALETTA BIO, INC. · 2024-12-31 CABALETTA BIO, INC. (edgar:1759138) Free cash flow: -90433000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -88222000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2199007 Filing: 000175913826000011 Input fundies:CapitalExpenditure: 2211000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2205602 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 167.86 million Exact value Exact value: -167856000 USD 2025-01-01 – 2025-12-31: -167856000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CABALETTA BIO, INC. · 2025-12-31 CABALETTA BIO, INC. (edgar:1759138) Net Income: -167856000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -167856000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2644441 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.	−USD 131.08 million Exact value Exact value: -131080000 USD 2025-01-01 – 2025-12-31: -131080000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CABALETTA BIO, INC. · 2025-12-31 CABALETTA BIO, INC. (edgar:1759138) Operating Cash Flow: -131080000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -131080000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2197147 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.	USD 1.23 million Exact value Exact value: 1229000 USD 2025-01-01 – 2025-12-31: 1229000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CABALETTA BIO, INC. · 2025-12-31 CABALETTA BIO, INC. (edgar:1759138) Capital Expenditure: 1229000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1229000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2203857 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.	−USD 132.31 million Calculation and evidence -131080000 − 1229000 USD Exact free cash flow: -132309000 USD 2025-01-01 – 2025-12-31: -131080000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 1229000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CABALETTA BIO, INC. · 2025-12-31 CABALETTA BIO, INC. (edgar:1759138) Free cash flow: -132309000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:21:17Z Snapshot: 5766b34c9fbb89fcb841250be5be59c32f3d61dc0029d36ffa7306c5c4d295aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1759138?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -131080000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2197147 Filing: 000175913826000011 Input fundies:CapitalExpenditure: 1229000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1759138/000175913826000011/caba-20251231.htm#2203857 Filing: 000175913826000011 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

44 filings · 1,497 latest values · 1,497 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001759138, 1759138, CABA, edgar:1759138

Also known as CABALETTA BIO, INC., Cabaletta Bio, Inc.

CABALETTA BIO, INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation